Metastatic Colorectal Cancer: Therapeutic Options for Treating Refractory Disease

Current Oncology - Canada
doi 10.3747/co.26.5575
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Antiangiogenic Therapy for Refractory Colorectal Cancer: Current Options and Future Strategies

Therapeutic Advances in Medical Oncology
Oncology
2016English

New Therapeutic Agents for Metastatic Colorectal Cancer: Literature Review

Colorectal Oncology
2018English

Targeting Metastatic Colorectal Cancer &Ndash; Present and Emerging Treatment Options

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2014English

Treatment Options for Refractory Kawasaki Disease

Yangtze Medicine
2020English

S‐1 Plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

Role of Capecitabine in Treating Metastatic Colorectal Cancer in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2014English

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities

Nanomaterials
Materials ScienceChemical Engineering
2018English

Real‐world Treatment Patterns and Outcomes in Refractory Metastatic Colorectal Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

An IL13Rα2 Peptide Exhibits Therapeutic Activity Against Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy